ArticleEuropean radiology2026
Segmentation of blush size guides embolic endpoints in genicular artery embolization.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Outcome and Safety of Genicular Artery Embolization for Knee Osteoarthritis: A Systematic Review and Meta-Analysis.Cardiovascular and interventional radiology · 2026Pooled it
- Multimodality imaging considerations for genicular artery embolization in knee osteoarthritis.World journal of radiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveTo identify a quantitative surrogate parameter for the embolic endpoint in genicular artery embolization (GAE). MATERIALS AND
methodsDigital subtraction angiography (DSA) images were fused and converted into color maps. Using segmentation software, blush size was measured before and after embolization, and blush reduction ratio (BRR) was calculated. Osteoarthritis severity was graded on radiographs, and clinical outcome was evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS) at 6 weeks, 3 months, and 6 months. Embolized vessels and embolic volume were recorded. Blush size and BRR were compared between osteoarthritis grades and across embolized vessels.
resultsGAE using 100-300 µm permanent microspheres was performed in 90 patients with mild to severe osteoarthritis and 23 patients with pain after total knee replacement (post-TKR) (404 vessels). The median number of vessels embolized per session was 4 (range: 1-6) with a median total embolic volume of 3.5 mL (1.1-8.0 mL). Pre-embolization blush size (+ 1116 mm²/osteoarthritis grade; p < 0.0001) and embolic volume (+ 1.1 mL/OA grade; p < 0.0001) increased with higher osteoarthritis grade and post-TKR. Blush size significantly decreased after embolization (p < 0.0001) with a median BRR of 0.81 (0.62-0.94). No significant differences in BRR were observed between osteoarthritis grades and different vessels. All KOOS subscales improved significantly at each follow-up (p < 0.0001).
conclusionSegmentation of blush size enables quantitative assessment of embolic endpoints across all genicular arteries and osteoarthritis grades, including post-TKR cases. "Pruning" corresponds to a blush size reduction of 80%. Higher osteoarthritis grades are associated with larger blush areas, requiring higher embolic volumes to achieve comparable embolic endpoints. KEY POINTS: Question Standardized, quantitative assessment of embolic endpoints in GAE is lacking, as the angiographic endpoint "pruning" has so far been defined only subjectively. Findings Segmentation of angiographic blush using color-coded maps enables objective quantification of embolic endpoints. With increasing osteoarthritis grade, baseline blush size and embolic volume increase, while an 80% blush reduction defines the endpoint "pruning." Clinical relevance Objective blush quantification improves the reproducibility of embolic endpoint assessment in GAE and supports individualized embolization strategies across disease severity and vascular territories.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.